Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile
Kumar Bharathkar, S.; Miller, M. J.; Stadtmueller, B. M.
Show abstract
Secretory (S) Immunoglobin (Ig) A is the predominant mucosal antibody, which mediates host interactions with commensal and pathogenic microbes, including Clostridioides difficile. SIgA adopts a polymeric IgA structure that is bound by secretory component (SC). Despite significance, how SIgA supports diverse effector mechanisms is poorly characterized and SIgA-based therapies nonexistent. We engineered chimeric (c) SIgAs, in which we replaced SC domain D2 with a single domain antibody or a monomeric fluorescent protein, allowing us to investigate and enhance SIgA effector mechanisms. cSIgAs exhibited increased neutralization potency against C. difficile toxins, promoted bacterial clumping and cell rupture, and decreased cytotoxicity. cSIgA also allowed us to visualize and/or quantify C. difficile morphological changes and clumping events. Results reveal mechanisms by which SIgA combats C. difficile infection, demonstrate that cSIgA design can modulate these mechanisms, and demonstrate cSIgAs adaptability to modifications that might target a broad range of antigens and effector mechanisms.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917 96%
- Pfs48/45 nanobodies block Plasmodium falciparum transmission 95%
- Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores 94%
Similar papers in this journal
- Opsonization by non-neutralizing antibodies can confer protection to SARS-CoV-2 despite Spike-dependent modulation of phagocytosis 95%
- Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment with TNF-alpha Antagonists 94%
- Harnessing mRNA for the expression of monoclonal IgG and IgA in non-human primates. 94%
Similar papers in this journal
- The impact of Staphylococcus aureus cell wall glycosylation on langerin recognition and Langerhans cell activation 93%
- Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative 93%
- The HCoV-HKU1 N-terminal domain binds a wide range of 9-O-acetylated sialic acids presented on different glycan cores 92%
Similar papers in this journal
- Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5 94%
- Phage-displayed synthetic library and screening platform for nanobody discovery 94%
- One N-glycan regulates natural killer cell antibody-dependent cell-mediated cytotoxicity and modulates Fc γ receptor IIIa / CD16a structure 93%
Similar papers in this journal
- A Protein A based Staphylococcus aureus vaccine with improved safety 95%
- Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants 94%
- A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.